/Investor DB

Boundary Capital

Impact investor

Northampton · Seed–Series A · 5 people tracked

Find your way into Boundary Capital

Sign up to see every warm intro you have to Boundary Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Boundary Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Boundary Capital backs high-growth private technology companies that it believes can positively impact millions of lives. The firm's team brings blue-chip commercial and academic experience across life sciences, artificial intelligence, and engineering, drawing on a track record of founding, investing in, and exiting multiple businesses. This combined operator and investor background informs a focus on technology-driven ventures with significant potential for scale and societal impact.

Source: firm website, verified Sep 24, 2026.

Stage
Seed–Series A
Check
$190.5K – $635K
HQ
Northampton, GB
Instruments
Equity
Founded
2009
Net assets · FY2025
$240.6K
Tracked investments
30
Acquisitions
1

Team · 5 people

from the firm's website & public directories
Adrian Parton· Partnerin
Damo Baliga· Partnerin𝕏
Richard Leaver· Partnerin𝕏

What they invest in

from 4 of 30 portfolio companies

AI & Machine Learning ×2Deep Tech ×2Biotech ×1Digital Health ×1EdTech ×1Fintech ×1Healthtech ×1Medical Devices ×1

HQs:United Kingdom×2

Investments · 30 tracked

founders shown can be your intro path

By year:2021 · 12018 · 22013 · 25 dated

Bodyswapsbodyswaps.coin

Bodyswaps provides immersive learning experiences, likely VR or virtual simulations, for educational institutions including further education colleges and apprenticeship providers.

AI & Machine LearningEdTechSaaSLondon, GB

Christophe Mallet(Chief Executive Officer)inTom Szirtes(Chief Product & Technology Officer)inJulien Denoel(Chief Operations Officer)in

Co-investorsHaatchUfi VocTech Trust

Glyconicsglyconics.comin𝕏Nov 2021

Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.

Deep TechDigital HealthHealthtechMedical Devices

Andrew Round(Chief Executive Officer (ad interim))Dr. Päivi Maria Paldánius(Chief Medical Officer & Chief Operating Officer)Sebastien Cuvelier Mussalian(Chief Technology Officer)Dr. Phil Taday(Head of R&D)Paul Jesson(Chief Finance Officer)

Co-investorsAnglia Capital GroupDeepbridge Capital

Hardman & Cohardmanandco.comin𝕏

This page is a podcast interview/article about Empirical Ventures, not a company website.

AI & Machine LearningDeep TechFintechLondon, GB

Johnathan Matlock(Co-founder and General Partner)

Natroxnatroxwoundcare.com

Advanced wound care therapy delivering continuous topical oxygen to accelerate healing.

Michael Clancy(Interim CEO)

Co-investorsAmadeus Capital Partners

Weedingtechweedingtech.com

Supplies machines and supplies that kill weeds without using herbicides.

Co-investorsCalculus Capital Ltd.Calculus

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BC ABBC Dymag MAIN HIGH RESBC EchionBC glyconicsBitcoin Farming AdvisoryBusinessBusiness MatchingBusiness StrategyCelixirDesktop GeneticsFinancialImage ScanInductosenseInvestingInvestmentMarket ResearchMeetingMergerMerger AcquisitionPlanningResearchStockTorsionTorsion Information SecurityWarwick Analytics

Exits · 1

1 acquisitions

Desktop Geneticsacq. by Celixir

Portfolio news

latest coverage across their companies
Haatch SEIS Fund | Hardman & Co

Hardman & Co · hardmanandco.com · Apr 29, 2026

Principals & officers · per Companies House

what is this? ⓘ
Daniel Peter Somers

Director · British · since 2009

Ownership & control

Daniel Peter Somers — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors, significant influence or control

Frequently asked questions

How many investments has Boundary Capital made?
Boundary Capital has 30 tracked investments, 1 of which have exited.
What stage does Boundary Capital invest at?
Boundary Capital invests at the Seed, Series A stages.
What is Boundary Capital's typical check size?
Boundary Capital typically writes checks of $190.5K – $635K.
What sectors does Boundary Capital focus on?
Boundary Capital focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Data & Infrastructure, Deep Tech, FoodTech, Healthtech, Impact & Social Good, Longevity.
Where is Boundary Capital located?
Boundary Capital is headquartered in Northampton, GB.
Who does Boundary Capital co-invest with?
Boundary Capital most often shares deals with Amadeus Capital Partners, Calculus Capital Ltd., Haatch, among 4 tracked co-investors.

Media · Podcasts & interviews

featuring the team

GrowthInvest Adviser Hour: Interview with Dan Somers of Boundary Capital

Boundary Capital · Dan

Images

X profile banner

Co-investors · 1

Sana Capital

Sana Capital invests in growth-stage healthcare businesses at the intersection of services and technology, focusing on sustainable solutions that improve access, outcomes, and costs while promoting health equity in underserved communities.

Firms observed investing alongside Boundary Capital, from public investor directories. Shared companies are the overlap with Boundary Capital's recorded portfolio.

Similar investors

Featured in lists